Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice

Journal of Virology

Volumn 74, Issue 11, 2000, Pages 5266-5272

  Madden, Charles R ^a   Finegold, Milton J ^a   Slagle, Betty L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CARCINOGEN; DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIOPHAGE LAMBDA; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; FEMALE; HEPATITIS B VIRUS; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; DNA; DNA DAMAGE; FEMALE; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; MUTAGENESIS; SEQUENCE ANALYSIS; TRANS-ACTIVATORS;

EID: 0034022192     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.11.5266-5272.2000     Document Type: Article

References (65)

1. Beasley, R. P. 1988. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
2. Becker, S. A., T. H. Lee, J. S. Butel, and B. L. Slagle. 1998. Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol. 72:266-272.
3. Benn, J., and R. J. Schneider. 1994. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. USA 91:10350-10354.
4. Benn. J., and R. J. Schneider. 1995. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad Sci. USA 92:11215-11219.
5. Billet, O., G. Grimber, M. Levrero, K. A. Seye, P. Briand, and V. Joulin. 1995. In vivo activity of the hepatitis B virus core promoter:tissue specificity and temporal regulation. J. Virol. 69:5912-5916.
6. Buendia, M. A. 1992. Hepatitis B viruses and hepatocellular carcinoma. Adv. Cancer Res. 59:167-226.
7. Callahan, J. D., and J. M. Short. 1995. Transgenic λ/lac 1 mutagenicity assay: statistical determination of sample size. Mutat. Res. 327:201-208.
8. Caselmann, W. H. 1996. Trans-activation of cellular genes by hepatitis B virus proteins: a possible mechanism of hepatocarcinogenesis. Adv. Virus Res. 47:253-302.
9. Chen, H.-S., S. Kaneko, R. Girones, R. W. Anderson, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1218-1226.
10. Chisari, F. V., K. Klopchin, T. Moriyama, C. Pasquinelli, H. A. Dunsford, S. Sell, C. A. Pinkert, R. L. Brinster, and R. D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156.
11. Christen, S., T. M. Hagen, M. K. Shigenaga, and B. N. Ames. 1999. Chronic inflammation, mutation, and cancer, p. 35-88. In J. Parsonel (ed.), Microbes and malignancy: infection as a cause of human cancers. Oxford University Press, New York, N.Y.
12. De-Medina, T., I. Haviv, S. Noiman, and Y. Shaul. 1994. The X protein of hepatitis B virus has a ribo-deoxy ATPase activity. Virology 202:401-407.
13. Doria, M., N. Klein, R. Lucito, and R. J. Schneider. 1995. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J. 19:4747-4757.
14. Dragani, T. A., G. Manenti, H. Farza, G. Della Porta, P. Tiollais, and C. Pourcel. 1989. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis. Carcinogenesis 11:953-956.
15. Enat, R., D. M. Jefferson, N. Ruiz-Opazo, Z. Gatmaitan, L. A. Leinwand, and L. M. Reid. 1984. Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc. Natl. Acad. Sci. USA 81:1411-1415.
16. Feitelson, M. A., and L. X. Duan. 1997. Hepatitis B virus x antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am. J. Pathol. 150:1141-1157.
17. Feitelson, M. A., M. Zhu, L. X. Duan, and W. T. London. 1993 Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109-1117.
18. Ghebranious, N., and S. Sell. 1998. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. Hepatology 27:383-391.
19. Gottlob, K., M. Fulco, M. Levrero, and A. Graessmann. 1998. The hepatitis B virus HBx protein inhibits caspase 3 activity. J. Biol. Chem. 273:33347-33353.
20. Groisman, I. J., R. Koshy, F. Henkler, J. D. Groopman, and M. A. Alaoui-Jamati. 1999. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells. Carcinocenesis 20:479-483.
21. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
22. Hagen, T. M., S. Huang, J. Curnutte, P. Fowler, V. Martinez, C. M. Wehr, B. N. Ames, and F. V. Chisari. 1994. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 91:12808-12812.
23. Hill, K. A., V. L. Buettner. B. W. Glickman, and S. S. Sommer. 1999. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived. Mutat. Res. 436:11-19.
24. Jakubczak, J. L., G. Merlino, J. E. French, W. J. Muller, B. Paul, S. Adhya, and S. Garges. 1996. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl. Acad. Sci. USA 93:9073-9078.
25. Jia, L., X. W. Wang, and C. C. Harris. 1999. Hepatitis B virus X protein inhibits nucleotide excision repair. Int. J. Cancer 80:875-879.
26. Kekule, A. S., U. Lauer, L. Weiss, B. Luber, and P. H. Hofschneider. 1993. Hepatitis B virus transactivator HBx uses a tumour promoter signaling pathway. Nature 361:742-745.
27. Kim, C.-M., K. Koike, I. Saito, T. Miyamura, and G. Jay. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320.
28. Kim, H., H. Lee, and Y. Yun. 1998. X-gene product of hepatitis B virus induces apoptosis in liver cells. J. Biol. Chem. 273:381-385.
29. Klein, N. P., and R. J. Schneider. 1997. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol. Cell. Biol. 17:6427-6436.
30. Kohler, S. W., G. S. Provost, P. L. Kretz, A. Fieck, and J. M. Short. 1990. An in vivo assay using transgenic mice to analyze spontaneous and induced mutations at the nucleic acid level. Strategies 3:19-21.
31. Koikie, K., K. Moriya, H. Yotsuyanagi, S. Iino, and K. Kurokawa. 1994. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Investig. 94:44-49.
32. Krishnamoorthy, R. R., T.-H. Lee, J. S. Butel, and H. K. Das. 1997. Apolipoprotein B gene regulatory factor-2 (BRF-2) is structurally and immunologically highly related to hepatitis B virus associated protein-I (XAP-1). Biochemistry 36:960-969.
33. Lee, T.-H., S. J. Elledge, and J. S. Butel. 1995. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J. Virol. 69:1107-1114.
34. Lee, T.-H., M. F. Finegold, R.-F. Shen, J. L. DeMayo, S. L. C. Woo, and J. S. Butel. 1990. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol. 64:5939-5947.
35. Lee, Y. H., and Y. Yun. 1998. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J. Biol. Chem. 273:25510-25515.
36. Marra, G., and P. Schar. 1999. Recognition of DNA alterations by the mismatch repair system. Biochem. J. 338:1-13.
37. Natoli, G., M. L. Avantaggiati, P. Chirillo, P. L. Puri, A. Ianni, C. Balsano, and M. Levrero. 1994. Ras-and Raf-dependent activation of c-Jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9:2837-2843.
38. Nomura, T., Y. Lin, D. Dorjsuren, S. Ohno, T. Yamashita, and S. Murakami. 1999. Human hepatitis B virus X protein is detectable in nuclei of transfected cells, and is active for transactivation, Biochim. Biophys. Acta 1453:330-340.
39. Perfumo, S., L. Amicone, S. Colloca, M. Giorgo, L. Pozzi, and M. Tripodi. 1992. Recognized efficiency of the hepatitis B virus polyadenylation signal is tissue specific in transgenic mice. J. Virol. 66:6819-6823.
40. Pollicino, T., O. Terradillos, H. Lecoeur, M. L. Gougeon, and M. A. Buendia. 1998. Pro-apoptotic effect of the hepatitis B virus X gene. Biomed. Pharmacother. 52:363-368.
41. Prost, S., J. M. Ford, C. Taylor, J. Doig, and D. J. Harrison. 1998. Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. J. Biol. Chem. 273:33327-33332.
42. Qadri, I., J. W. Conaway, R. C. Conaway, J. Schaack, and A. Siddiqui. 1996. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc. Natl. Acad. Sci. USA 93:10578-10583.
43. Reifenberg, K., J. Lohler, H.-P. Pudollek, E. Schmitteckert, G. Spindler, J. Kock, and H.-J. Schlickt. 1999. Long-term expression of the hepatitis B virus core-e-and X-proteins does not cause pathologic changes in transgenic mice. J. Hepatol. 26:119-130.
44. Ross, J. A., and S. A. Leavitt. 1998. Induction of mutations by 2-acetylaminofluorene in lac 1 transgenic B6C3F1 mouse liver. Mutagenesis 13:173-179.
45. Rossner, M. T. 1992. Hepatitis B virus X-gene product: a promiscuous transcriptional activator. J. Med. Virol. 36:101-117.
46. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
47. Sancar, A. 1996. DNA excision repair. Annu. Rev. Biochem. 65:43-81. (Erratum, 66:VII, 1997.)
48. Sitterlin, D., T.-H. Lee, S. Prigent, P. Tiollais, J. S. Butel, and C. Transy. 1997. Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J. Virol. 71:6194-6199.
49. Slagle, B. L., S. A. Becker, and J. S. Butel. 1994. Hepatitis viruses and liver cancer, p. 149-171. In A. Minson, J. Neil, and M. McCrae (ed.), Viruses and cancer, vol. 51. University of Cambridge, Cambridge, England.
50. Slagle, B. L., T.-H. Lee, D. Medina, M. J. Finegold, and J. S. Butel. 1996. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog. 15:261-269.
51. Slagle, B. L., T.-H. Lee, and J. S. Butel. 1992. Hepatitis B virus and hepatocellular carcinoma. Prog. Med. Virol. 39:167-203.
52. Su, F., and R. J. Schneider. 1997. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor a. Proc. Natl. Acad. Sci. USA 94:8744-8749.
53. Sun, Z., P. Lu, M. H. Gail, D. Pee, Q. Zhang, L. Ming, J. Wang, Y. Wu, G. Liu, and Y. Zhu. 1999. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 30:379-383.
54. Terradillos, O., O. Billet, C. A. Renard, R. Levy, T. Molina, P. Briand, and M. A. Buendia. 1997. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14:395-404.
55. Terradillos, O., T. Pollicino, H. Lecoeur, M. Tripodi, M. L. Gougeon, P. Tiollais, and M. A. Buendia. 1998. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17:2115-2123.
56. Wang, W. L., W. T. London, L. Lega, and M. A. Feitelson. 1991. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14:29-37.
57. Wang, X. W., K. Forrester, H. Yeh, M. A. Feitelson, J. R. Gu, and C. C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA 91:2230-2234.
58. Wang, X. W., M. K. Gibson, W. Vermeulen, H. Yeh, K. Forrester, H.-W. Sturzbecher, J. H. J. Hoeijmakers, and C. C. Harris. 1995. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55:6012-6016.
59. Williams, G. M., M. F. Laspia, and V. C. Dunkel. 1982. Reliability of the hepatocyte primary culture/DNA repair test in testing of coded carcinogens and non-carcinogens. Mutat. Res. 97:359-370.
60. Wood, R. D. 1996. DNA repair in eukaryotes. Annu. Rev. Biochem. 67:135-167.
61. Wyllie, A. H., C. O. Bellamy, V. J. Bubb, A. R. Clarke, S. Corbet, L. Curtis, D. J. Harrison, M. L. Hooper, N. Toft, S. Webb, and C. C. Bird. 1999. Apoptosis and carcinogenesis. Br. J. Cancer 80(Suppl. 1):34-37.
62. Yeh, F.-S., M. C. Yu, C.-C. Mo, S. Luo, M. J. Tong, and B. E. Henderson. 1989. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49:2506-2509.
63. Yoo, Y. D., H. Ueda, K. Park, K. C. Flanders, Y. I. Lee, G. Jay, and S. J. Kim. 1996. Regulation of transforming growth factor-β1 expression by the hepatitis B virus (HBV) X transactivator. J. Clin. Investig. 97:388-395.
64. Yu, D. Y., H. B. Moon, J. K. Son, S. Jeong, S. L. Yu, H. Yoon, Y. M. Han, C. S. Lee, J. S. Park, C. H. Lee, B. H. Hyun, S. Murakami, and K. K. Lee. 1999. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J. Hepatol. 31:123-132.
65. Zoulim, F., J. Saputelli, and C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030.